Clinical Trials
4 trialsNCT01332279 2023-04-04
Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation Therapy
Fox Chase Cancer Center
Phase 1 Withdrawn
NCT01333085 2016-02-10
CAPRA
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 1/2 Completed
NCT01637194 2012-07-11
Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer
Fox Chase Cancer Center
Phase 1 Completed
NCT01313390 2011-12-12
DORA
University College, London
Phase 1/2 Terminated